Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Solid Biosciences Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 40 | 56 | +16 |
| Shares | 16.6M | 35.0M | +18.4M (+110.4%) |
| Value | $102.2M | $465.9M | +$363.7M (+355.8%) |
New holders (22)
Institutions that held Solid Biosciences Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (6)
Institutions that held Solid Biosciences Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Camber Capital Management LP | 1,418,439 | $8.71M |
| Bank of Montreal | 131,500 | $900.8K |
| AJOVista, LLC | 3,806 | $23.4K |
| Tower Research Capital LLC (TRC) | 1,555 | $9.55K |
| Simplex Trading, LLC | 537 | $3.00K |
| FMR LLC | 6 | $37 |